Stabilization and maintenance

Description: 
A reference tool used to provide clinicians with stabilization resources for substance use disorder within active duty and veteran populations, including resources on pharmacological treatment and substance titration.
Source: 
VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders
field_vote: 
Resource Type: 
Description: 
Guidelines from Boston Medical Center designed for patient maintained on buprenorphine underdoing invasive procedures.
Source: 
Colleen LaBelle, Boston Medical Center
field_vote: 
Description: 
This web page provides brief recommendations for monitoring patients undergoing buprenorphine treatment using liver function tests, and the proper actions to take if a patient develops hepatitis.
Source: 
PCSS Guidance
field_vote: 
Description: 
Journal abstract that examines whether there's an association of ethnicity and race with treatment response to buprenorphine.
Source: 
Brown, et al., Department of Psychiatry, The University of Texas Southwestern Medical Center
field_vote: 
Resource Type: 
Description: 
This article provides guidance on the treatment of alcohol and drug abuse, and discusses various treatment plans.
Source: 
National Institute on Drug Abuse (NIDA)
field_vote: 
Resource Type: 
Description: 
This chapter from TIP 43: Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs discusses the use of drug testing as a means of monitoring patient progress and treatment efficacy. This chapter details several methods for implementing drug testing, their effectiveness, and their pros and cons.
Source: 
Center for Substance Abuse Treatment (CSAT)
field_vote: 
Resource Type: 

Withdrawal Versus Precipitated Withdrawal

Description: 
Two types of withdrawal are associated with mu opioid agonist dependence: withdrawal and precipitated withdrawal.

Habitual opioid users become dependent on opioids. Dependent individuals who stop or decrease opioid use may go into spontaneous withdrawal. Dependent individuals who take an opioid antagonist (or partial agonist, in some cases) may go into precipitated withdrawal.

field_vote: 
Physician stage in practice: 
Description: 
This journal article compares the effectiveness of detoxification vs. continuing buprenorphine-naloxone therapy for treating opioid-addicted adolescents. The study followed 152 patients between the ages of 15 and 21 who were randomly selected to receive either a 12-week buprenorphone-naloxone program, or a 14-day taper.
Source: 
The Journal of the American Medical Association (JAMA)
field_vote: 
Physician stage in practice: 
Resource Type: 

Pages

Subscribe to Stabilization and maintenance